Xia Yuan

1.2k total citations
33 papers, 878 citations indexed

About

Xia Yuan is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Xia Yuan has authored 33 papers receiving a total of 878 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 9 papers in Oncology and 6 papers in Cancer Research. Recurrent topics in Xia Yuan's work include Ubiquitin and proteasome pathways (6 papers), MicroRNA in disease regulation (3 papers) and Immune cells in cancer (3 papers). Xia Yuan is often cited by papers focused on Ubiquitin and proteasome pathways (6 papers), MicroRNA in disease regulation (3 papers) and Immune cells in cancer (3 papers). Xia Yuan collaborates with scholars based in China, Canada and United States. Xia Yuan's co-authors include Xuelei Ma, Li Liu, Fei Mo, Mao Ye, Dan Li, Wei Du, Jing Zhang, Shuo Zhang, Guoping Wang and Chenjing Zhu and has published in prestigious journals such as Journal of the American Chemical Society, PLoS ONE and Molecules.

In The Last Decade

Xia Yuan

31 papers receiving 871 citations

Peers

Xia Yuan

IMMUN

ONCOL

PRM

Mohammad Althubiti Saudi Arabia

Ercan Çaçan Türkiye

John F. Woolley United Kingdom

Iwona Wertel Poland

Jiamo Lu United States

Jiaming Xie China

Ewa Marcinkowska Poland

Lefkothea C. Papadopoulou Greece

Rossella Marullo United States

Maciej Małecki Poland

Mohammad Althubiti Saudi Arabia

Xia Yuan

423 ×1.3

124 ×0.4

IMMUN

164 ×0.6

ONCOL

111 ×1.0

71 ×1.0

PRM

Citations per year, relative to Xia Yuan Xia Yuan (= 1×) peers Mohammad Althubiti

Countries citing papers authored by Xia Yuan

Since Specialization

Citations

This map shows the geographic impact of Xia Yuan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xia Yuan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xia Yuan more than expected).

Fields of papers citing papers by Xia Yuan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xia Yuan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xia Yuan. The network helps show where Xia Yuan may publish in the future.

Co-authorship network of co-authors of Xia Yuan

This figure shows the co-authorship network connecting the top 25 collaborators of Xia Yuan. A scholar is included among the top collaborators of Xia Yuan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xia Yuan. Xia Yuan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Huang, Rui, Xia Yuan, Yu Liu, et al.. (2025). Vision-Based Obstacle Avoidance and Formation Control for Underwater Robotic Fish. IEEE Robotics and Automation Letters. 10(10). 10442–10449.

Li, Jun, Weizhen Huang, Junjie Kuang, et al.. (2025). Integrated multiomics analysis highlights the immunosuppressive role of granulin precursor positive macrophages in hepatocellular carcinoma. PeerJ. 13. e18879–e18879.

Zhu, Yuejie, Qi Zhang, Xudong Sun, et al.. (2024). Aptamer AS411 interacts with the KRAS promoter/hnRNP A1 complex and shows increased potency against drug-resistant lung cancer. RSC Medicinal Chemistry. 15(5). 1515–1526. 2 indexed citations

Yuan, Xia, Dan Wang, Huijie Zhao, et al.. (2024). Silencing of tropomodulin 1 inhibits acute myeloid leukemia cell proliferation and tumor growth by elevating karyopherin alpha 2–mediated autophagy. Pharmacological Research. 207. 107327–107327. 6 indexed citations

Li, Peng, Dongmei Wang, Xia Yuan, et al.. (2024). RHOF activation of AKT/β-catenin signaling pathway drives acute myeloid leukemia progression and chemotherapy resistance. iScience. 27(7). 110221–110221. 2 indexed citations

Ding, Yi, et al.. (2021). Circular RNA RBM33 contributes to cervical cancer progression via modulation of the miR-758-3p/PUM2 axis. Journal of Molecular Histology. 52(2). 173–185. 16 indexed citations

Yuan, Xia, Wen Nie, Zhiyao He, et al.. (2020). Carbon black nanoparticles induce cell necrosis through lysosomal membrane permeabilization and cause subsequent inflammatory response. Theranostics. 10(10). 4589–4605. 53 indexed citations

Liu, Bin, Xia Yuan, Bo Xu, et al.. (2019). Synthesis of novel 7-azaindole derivatives containing pyridin-3-ylmethyl dithiocarbamate moiety as potent PKM2 activators and PKM2 nucleus translocation inhibitors. European Journal of Medicinal Chemistry. 170. 1–15. 27 indexed citations

Liu, Dandan, Xia Yuan, Shifeng Chu, et al.. (2018). CZ-7, a new derivative of Claulansine F, ameliorates 2VO-induced vascular dementia in rats through a Nrf2-mediated antioxidant responses. Acta Pharmacologica Sinica. 40(4). 425–440. 33 indexed citations

10.

Yuan, Xia, Jing Zhang, Dan Li, et al.. (2017). Prognostic significance of tumor-associated macrophages in ovarian cancer: A meta-analysis. Gynecologic Oncology. 147(1). 181–187. 194 indexed citations

11.

Huang, Wei, Xia Yuan, Ting Sun, et al.. (2017). Proteasome Inhibitor YSY01A Abrogates Constitutive STAT3 Signaling via Down-regulation of Gp130 and JAK2 in Human A549 Lung Cancer Cells. Frontiers in Pharmacology. 8. 476–476. 9 indexed citations

12.

Zhang, Shuo, Xuelei Ma, Chenjing Zhu, et al.. (2016). The Role of Myeloid-Derived Suppressor Cells in Patients with Solid Tumors: A Meta-Analysis. PLoS ONE. 11(10). e0164514–e0164514. 138 indexed citations

13.

Han, Liqiang, Xia Yuan, Xingyu Wu, et al.. (2016). Urea-containing peptide boronic acids as potent proteasome inhibitors. European Journal of Medicinal Chemistry. 125. 925–939. 26 indexed citations

14.

Huang, Wei, Xia Yuan, Bo Xu, et al.. (2015). YSY01A, a Novel Proteasome Inhibitor, Induces Cell Cycle Arrest on G2 Phase in MCF-7 Cells via ERα and PI3K/Akt Pathways. Journal of Cancer. 6(4). 319–326. 10 indexed citations

15.

Zhang, Mei, Xia Yuan, Bo Xu, et al.. (2015). Anticancer Effect of a Novel Proteasome Inhibitor, YSY01A, via G2/M Arrest in PC-3M Cells in vitro and in vivo. Journal of Cancer. 6(8). 701–708. 3 indexed citations

16.

Zhong, Zhangfeng, Yuanye Dang, Xia Yuan, et al.. (2012). Furanodiene, a Natural Product, Inhibits Breast Cancer Growth Bothin vitroandin vivo. Cellular Physiology and Biochemistry. 30(3). 778–790. 49 indexed citations

17.

Xu, Bo, Wei Guo, Jingtao Liu, et al.. (2012). Pseudolaric acid B inhibits inducible cyclooxygenase-2 expression via downregulation of the NF-κB pathway in HT-29 cells. Journal of Cancer Research and Clinical Oncology. 138(5). 885–896. 13 indexed citations

18.

Yuan, Xia. (2010). Procyanidins’Impact on SOD Activity,MDA Content in Rats Exposed to Cadmium in Serum and Liver. China Modern Doctor. 2 indexed citations

19.

Yuan, Xia, James A. White, Raymond Yee, & Maria Drangova. (2007). Tissue Doppler Imaging of Mitral Annular Motion Is an Effective Surrogate of Left Ventricular Dyssynchrony and Predicts Response to Cardiac Resynchronization Therapy. Journal of the American Society of Echocardiography. 20(10). 1186–1193. 1 indexed citations

20.

Yuan, Xia, David S. Bach, Allan C. Skanes, & Maria Drangova. (2004). Assessment of intra- and interobserver variability of pulmonary vein measurements from CT angiography1. Academic Radiology. 11(11). 1211–1218. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact